期刊文献+

GDF9和BMP15在PCOS患者刺激周期卵母细胞不同成熟阶段的表达变化及意义 被引量:8

Change and significance of growth differentiation factor 9 and bone morphogenetic protein expression during oocyte maturation in polycystic ovary syndrome patients with ovarian
原文传递
导出
摘要 目的 探讨卵源性因子——生长分化因子9(GDF9)和骨形态发生蛋白15(BMP15)在多囊卵巢综合征(PCOS)患者及因男方因素不孕的卵巢功能正常妇女刺激周期卵母细胞不同成熟阶段的表达变化及意义.方法 收集12例PCOS患者(PCOS组)的25个卵母细胞[9个胚泡(CV)期,9个MⅠ期和7个M Ⅱ期]和56例卵巢功能正常妇女(对照组)的82个卵母细胞(29个GV期,26个MⅠ期和27个MⅡ期),采用巢式实时定量PCR技术,检测两组妇女不同成熟阶段的卵母细胞中GDF9和BMP15 mRNA的表达水平.结果(1)GDF9 mRNA的表达水平:PCOS组GV、MⅠ、MⅡ期卵母细胞GDF9 mRNA的表达水平分别为44.8(4.2 ~529.0)、27.6(9.8~172.7)和49.0(0.2~65.9),对照组GV、MⅠ、MⅡ期卵母细胞GDF9 mRNA的表达水平分别为149.9(55.4 ~ 387.9)、29.9(2.5 ~205.8)和657.8(149.4 ~1376.2),两组妇女MⅡ期卵母细胞GDF9 mRNA的表达水平分别比较,差异有统计学意义(P<0.01),但两组妇女GV、MⅠ期卵母细胞GDF9 mRNA的表达水平比较,差异无统计学意义(P>0.05);PCOS组不同成熟阶段卵母细胞GDF9 mRNA的表达水平比较,差异无统计学意义(P>0.05),对照组不同成熟阶段卵母细胞GDF9 mRNA的表达水平分别比较,差异均有统计学意义(P <0.05、P<0.01).(2)BMP15 mRNA的表达水平:PCOS组GV、MⅠ、MⅡ期卵母细胞BMP15 mRNA的表达水平分别为0.1(0.1 ~22.0)、3.2(0.6~55.0)和6.4(3.2~8.5),对照组GV、MⅠ、MⅡ期卵母细胞BMP15 mRNA的表达水平分别为41.6(6.5 ~96.1)、4.0(2.0~10.4)和49.7(2.3 ~139.5),两组妇女GV期卵母细胞BMP15 mRNA的表达比较,差异有统计学意义(P<0.01),但两组MⅠ、MⅡ期卵母细胞BMP15 mRNA的表达水平比较,差异均无统计学意义(P>0.05);PCOS组不同成熟阶段卵母细胞BMP15 mRNA的表达水平比较,差异无统计学意义(P>0.05),对照组不同成熟阶段卵母细胞BMP15 mRNA的表达水平比较,GV期高于MⅠ期(P<0.05),MⅠ期低于MⅡ期(P<0.01).结论在刺激周期中,PCOS患者成熟卵母细胞中卵源性因子表达水平降低,可能影响细胞质成熟,从而导致PCOS患者卵母细胞质量下降和发育潜能受损. Objective To investigate the expression pattern and significance of two importantoocyte-secreted factors:growth differentiation factor 9(GDF9)and bone morphogenetic protein 15(BMP15)during oocyte maturation in women with polycystic ovary syndrome(PCOS)and infertile women due to husband factors.Methods Total of 25 oocytes[9 at germinal vesicle GV stage,9 at M Ⅰ stage and 7 at M Ⅱ stage]were obtained from 12 patients with PCOS and 82 oocytes(29 at GV stage,26 at M Ⅰ stage and 27 at M Ⅱ stage)were from 56 controls.The nested quantitative real time(RT)PCR was uscd to detect the abundance of GDF9 and BMP15 mRNA in each oocyte.Results(1)The expression level of GDF9 mRNA at the GV stage,M Ⅰ stage and M Ⅱ stage in PCOS group were 44.8(4.2-529.0),27.6(9.8-172.7)and 49.0(0.2-65.9)respectively,the expression in were 149.9(55.4-387.9),29.9(2.5-205.8)and 657.8(149.4-1376.2)in control group,respectively.The expression of GDF9 mRNA at M Ⅱ stage was significantly lower in PCOS group than in controls(P 〈 0.01),however,the differences didn't reach statistical significant at GV or M Ⅰ stage between the two groups(P 〉 0.05).The expression of GDF9 mRNA displayed some changes at different maturation stage in controls(P 〈 0.05,P 〈 0.01),however,the expression didn't demonstrate any dynamic changes in PCOS group(P 〉 0.05).(2)The expression level BMP15 mRNA at the GV stage,M Ⅰ stage and M Ⅱ stage in PCOS group were 0.1(0.1-22.0),3.2(0.6-55.0)and 6.4(3.2-8.5),respectively,the expression were 41.6(6.5-96.1),4.0(2.0-10.4)and 49.7(2.3-139.5)in control group,respectively.The expression of BMP15 mRNA at GV stage was significantly lower in PCOS group than in controls(P 〈 0.01),however,the differences were not significant at M Ⅰ or M Ⅱ stage between the two groups(P 〉0.05).The expression of BMP15 mRNA also displayed some changes at different maturation stage in controls(P 〈 0.05),however,the level didn't demonstrate any dynamic changes in PCOS group(P 〉 0.05).Conclusion It was suggested that the low expression of oocyte secreted factors in mature oocytes from PCOS patients might be associated with impaired oocyte quality and developmental competence in PCOS.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2012年第11期818-822,共5页 Chinese Journal of Obstetrics and Gynecology
基金 国家自然科学基金(30973202) 广东省教育部产学研结合项目 (2008B090500194) 高等学校博士学科专项科研基金(20090171110059)
关键词 生长分化因子9 骨形态发生蛋白质15 多囊卵巢综合征 卵母细胞 Growth differentiation factor 9 Bone morphogenctic protein 15 Polycystic ovary syndrome Oocytes
  • 相关文献

参考文献16

  • 1Teede H, Deeks A, Moran L. Polycystic ovary syndrome: acomplex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med,2010,8:41.
  • 2Maciel GA, Baracat EC, Benda JA, et al. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2004,89 : 5321-5327.
  • 3Teixeira FL, Baracat EC, Lee TH, et al. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab,2002,87:1337-1344.
  • 4Juengel JL, MeNatty KP. The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum Reprod Update,2005,11:143-160.
  • 5Gilchrist RB, Lane M, Thompson JG. Oocyte-secreted factors : regulators of cumulus cell function and oocyte quality. Hum Reprod Update ,2008,14 : 159-177.
  • 6Yan C, Wang P, DeMayo J, et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol,2001,15 :854-866.
  • 7Hussein TS, Thompson JG, Gilchrist RB. Oocyte-secreted factors enhance oocyte developmental competence. Dev Biol, 2006,296 : 514-521.
  • 8Boomsma CM, Eijkemans MJ, Hughes EG, et al. A meta- analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update,2006,12:673-683.
  • 9Li HK, Kuo TY, Yang HS, et al. Differential gene expression of bone morphogenetic protein 15 and growth differentiation factor 9 during in vitro maturation of porcine oocytes and early embryos. Anim Reprod Sci,2008,103:312-322.
  • 10Bebbere D, Bogliolo L, Ariu F, et al. Expression pattern of zygote arrest 1 ( ZAR1 ), maternal antigen that embryo requires (MATER), growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) genes in ovine oocytes and in vitro-produced preimplantation embryos. Reprod Fertil Dev,2008, 20:908-915.

同被引文献113

  • 1刘萍,李桂荣.多囊卵巢综合征伴不孕患者促排卵治疗后子宫动脉及其分支血流动力学研究[J].中国全科医学,2009,12(7):609-610. 被引量:16
  • 2张丽红,王克华,李娟,江平,张梅心,董云玲,胥玉梅,刘锦云,张琦,王洪岩.缩短受精前卵母细胞培养和精卵共孵育时间对妊娠结局的影响[J].生殖医学杂志,2006,15(2):127-129. 被引量:17
  • 3曾海涛,梁晓燕,姚书忠,沈宏伟,焦泽旭,舒益民,庄广伦.多囊卵巢综合征卵泡颗粒细胞提前对黄体生成素反应[J].中国病理生理杂志,2007,23(2):373-375. 被引量:12
  • 4辛茶香,刘珍琼,熊国亮.荧光定量PCR技术检测结核分支杆菌DNA的应用价值[J].国际检验医学杂志,2007,28(3):196-197. 被引量:25
  • 5World Health Organization. WHO Global Tuberculosis Report 2012 [ DB/OL ]. WHO/HTM/TB/2012. 6 . Geneva: WHO 2013. http://www, who. int/tb/pubtications/global- report/en/index. html.
  • 6Ishihara K, Inokuchi N, Tsushima Y, et al. Relevance of molecular tests for HTLV-1 infection as confirmatory tests after the first sero- screening [ J ]. J Immunoassay Immunochem, 2014, 35 ( 1 ) : 74-82.
  • 7Hemandez-Arteaga S, Lopez-Revilla R. Uhrasensitive quantitation of human papillomavirus type 16 E6 oncogene sequences by nested real time PCR[ J]. Infect Agents Cancer, 2010, 5: 9-16.
  • 8Wang JY, Lee LN, Chou CS, et al. Performance assessment of a nested-PCR assay (the RAPID BAP-MTB ) and the BD ProbeTec ET system for detection of Mycobacterium tuberculosis in clinical specimens [ J ]. J Clin Mierobiol, 2004, 42 (10) : 4599-4603.
  • 9Takahashi T, Nakayama T. Novel technique of quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA [ J ]. J Clin Microbiol, 2006, 44(3) : 1029-1039.
  • 10Takahashi T, Tamura M, Asami Y, et al. Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: clinical application for diagnosis of tuberculous meningitis [ J ]. J Clin Microbiol, 2008, 46(5) : 1698-1707.

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部